1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    Happy man working on his laptop.
    Blue Chip Shares

    3 ASX blue chips to buy before earnings season

    | James Mickleboro

    Analysts recently named these shares as buys. Let's see what they are recommending.

    Read more »

    A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
    Broker Notes

    Buy the dip on these 2 ASX 200 shares: experts

    | Bronwyn Allen

    Experts say these 2 ASX 200 shares are a buying opportunity today.

    Read more »

    A woman presenting company news to investors looks back at the camera and smiles.
    Blue Chip Shares

    2 of the best ASX 200 blue chip shares to buy now

    | James Mickleboro

    Bell Potter sees these as the creme de la creme right now.

    Read more »

    Cropped shot of an attractive young female scientist working on her computer in the laboratory.
    Healthcare Shares

    Why CSL shares are a buy today despite the looming Trump tariffs

    | Bernd Struben

    A leading expert believes CSL shares are still trading for a bargain today. Here's why.

    Read more »

    Senior man wearing glasses and a leather jacket works on his laptop in a cafe.
    Broker Notes

    Should I still swap my CSL for CBA shares or has the market corrected?

    | Laura Stewart

    The two stocks have travelled opposite directions this month.

    Read more »

    a man holds a firework sparkler in both hands as a shower of sparkly confetti falls from the sky around him as he smiles and closes his eyes in a celebratory scene.
    Broker Notes

    Stock market outlook: Macquarie 'ready to party like its 1999'

    | James Mickleboro

    It may not be too late to invest in the share market according to the broker.

    Read more »

    Man pointing an upward line on a bar graph symbolising a rising share price.
    How to invest

    How to invest when the ASX hits a record high

    | James Mickleboro

    Worried about buying at today's prices? Here's why you shouldn't be concerned.

    Read more »

    A young man looks at a stylised investment graph superimposed on an exterior office building backdrop.
    Growth Shares

    Where to invest $10,000 in ASX 200 stocks today

    | James Mickleboro

    Analysts think these high-quality shares are in the buy zone for investors right now.

    Read more »

    Person holding a blue chip.
    Opinions

    Buy alert! 2 ASX 200 blue-chip shares worth a look now: expert

    | Bronwyn Allen

    Dylan Evans from Catapult Wealth has identified two blue-chip shares that he thinks are good buys today.

    Read more »

    A group of people in a corporate setting do a collective high five.
    Healthcare Shares

    Should I buy Pro Medicus or CSL shares ahead of earnings season?

    | Laura Stewart

    The ASX healthcare sector may be currently undervalued.

    Read more »

    A couple sit in front of a laptop reading ASX shares news articles and learning about ASX 200 bargain buys
    Share Market News

    Are blue-chip stocks or ASX ETFs a better investment?

    | Aaron Bell

    Lets compare these two investment options based on long term returns. 

    Read more »

    A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    | James Mickleboro

    Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note